Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 20/100

Failure Rate

14.3%

3 terminated/withdrawn out of 21 trials

Success Rate

81.3%

-5.3% vs industry average

Late-Stage Pipeline

38%

8 trials in Phase 3/4

Results Transparency

108%

14 of 13 completed trials have results

Key Signals

3 recruiting14 with results

Enrollment Performance

Analytics

N/A
10(50.0%)
Phase 3
8(40.0%)
Phase 2
1(5.0%)
Phase 1
1(5.0%)
20Total
N/A(10)
Phase 3(8)
Phase 2(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials
NCT07470164Phase 3Not Yet Recruiting

Botulinum Toxin A vs Strabismus Surgery for Esotropia

Role: collaborator

NCT04378790Phase 3Recruiting

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

Role: collaborator

NCT06524882Phase 3Recruiting

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age

Role: collaborator

NCT06380517Phase 3Recruiting

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

Role: collaborator

NCT04634578Phase 2Active Not Recruiting

Bevacizumab Treatment For Type 1 ROP

Role: collaborator

NCT05462821Phase 3Completed

Full-Time Occlusion Therapy for Intermittent Exotropia in Children

Role: collaborator

NCT05527015Phase 3Withdrawn

Bifocal Spectacles vs. Single Vision Spectacles for Esotropia Greater at Near

Role: collaborator

NCT04634604Phase 3Terminated

A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP

Role: collaborator

NCT01032603Not ApplicableCompleted

Bilateral Lateral Rectus Recession Versus Unilateral Recess-Resect for Intermittent Exotropia

Role: collaborator

NCT03998670Not ApplicableCompleted

Base-in Prism Spectacles for Intermittent Exotropia

Role: collaborator

NCT03334253Phase 3Completed

Low-Dose Atropine for Treatment of Myopia

Role: collaborator

NCT02510040Completed

A Prospective Observational Study of Adult Strabismus

Role: collaborator

NCT02390531Phase 1Completed

Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity

Role: collaborator

NCT02807350Not ApplicableCompleted

Trial of Overminus Spectacle Therapy for Intermittent Exotropia

Role: collaborator

NCT02983552Not ApplicableCompleted

Binocular Dig Rush Game Treatment for Amblyopia

Role: collaborator

NCT03342235Not ApplicableWithdrawn

Excimer Laser Surgery for Anisometropic Amblyopia

Role: collaborator

NCT01032330Not ApplicableCompleted

Observation Versus Occlusion Therapy for Intermittent Exotropia

Role: collaborator

NCT01515475Not ApplicableCompleted

Hyperopia Treatment Study 1 (HTS1) - Glasses vs Observation

Role: collaborator

NCT02200211Not ApplicableCompleted

Study of Binocular Computer Activities for Treatment of Amblyopia

Role: collaborator

NCT02223650Not ApplicableCompleted

A Pilot Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia

Role: collaborator